產(chǎn)品搜索
相關(guān)文章
- PD-1阻斷療法激活的T細(xì)胞還需依賴CD28共刺激
- 一個好的ATCC細(xì)胞株有多方面要求
- 【連載-企業(yè)參考品】 前列腺癌的診斷參考品的選擇
- 有關(guān)腫瘤細(xì)胞的基因突變研究講解
- ATCC細(xì)胞的貼壁過程有何特點(diǎn)呢?
- IL2細(xì)胞篩選模型
- 【靶點(diǎn)模型+診斷質(zhì)控】BCR-ABL1的藥物開發(fā)和診斷
- *針對肝癌的PD-1抗體獲FDA批準(zhǔn),國產(chǎn)PD-1抗體進(jìn)入三期
- Cell Metab:雙信號通路失調(diào)協(xié)同促進(jìn)肺癌形成
- 【連載-企業(yè)參考品】胃癌的診斷參考品的選擇
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
電話:4008750250
號碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73293c-Kit W557G/BaF3
- 詳細(xì)內(nèi)容
CBP73293 | |
| I. Introduction | |
Cell Line Name: | c-Kit W557G/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
| II.Background | |
KIT W557G lies within the juxtamembrane domain (exon 11) of the Kit protein (PMID: 16226710). W557G results in constitutive phosphorylation of Kit in cell culture (PMID: 23567324), and therefore, is predicted to lead to a gain of Kit protein function. | |
| III. Representative Data | |
1. WB of c-Kit W557G/BaF3
| |
2. Sanger of c-Kit W557G/BaF3
| |
3. Anti-proliferation assay
Figure 3. CTG Proliferation Assay of BaF3 c-KIT W557G Cells (C4). | |
| |







